Protection of trinitrobenzene sulfonic acid–induced colitis by an interleukin 2–IgG2b fusion protein in mice
Open Access
- 31 October 1999
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 117 (4) , 866-876
- https://doi.org/10.1016/s0016-5085(99)70345-8
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammationImmunology Today, 1997
- Effects of IL-12 and Antibodies to IL-12 on Established Granulomatous Colitis in MiceAnnals of the New York Academy of Sciences, 1996
- Measurement of intracellular cytokinesImmunology Today, 1996
- Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group.Gut, 1995
- CTLA4Ig PROLONGS ALLOGRAFT SURVIVAL WHILE SUPPRESSING CELL-MEDIATED IMMUNITYTransplantation, 1994
- Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cellsPublished by Elsevier ,1994
- Interleukin‐10 Inhibits Antimicrobial Activity Against Leishmania major in Murine MacrophagesScandinavian Journal of Immunology, 1994
- Treatment of Murine Lupus with CTLA4IgScience, 1994
- Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation MoleculeScience, 1992
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lgScience, 1992